Joshua Reynolds MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
48 published records · newest first.
Written questions
Folic AcidDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11338More
Question: To ask the Secretary of State for Health and Social Care, what is the evidence base for mandatory fortification of white flour with folic acid; what consideration has been given to potential risks associated with long term population-wide exposure; and if
Answer: Government laid legislation in England on 14 November 2024 to introduce the mandatory fortification of non-wholemeal wheat flour with folic acid. The policy is estimated to prevent approximately 200 babies being born with neural tube defects each year. Le...
Answered 1 Jul 2026
Original Parliament recordBlood Tests: General PractitionersDepartment of Health and Social CareTabled 15 Jun 2026AnsweredUIN 9893More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of enabling patients to attend any NHS phlebotomy services for blood tests requested by their GP irrespective of the pathology
Answer: Decisions on the organisation of phlebotomy and pathology services are made locally by integrated care boards and National Health Service providers, reflecting local clinical pathways, safety requirements, and operational arrangements. This includes ensur...
Answered 22 Jun 2026
Original Parliament recordPathology: ICTDepartment of Health and Social CareTabled 15 Jun 2026AnsweredUIN 9892More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that pathology test results can be transferred electronically between NHS pathology providers and GP practices that use different laboratory informatio
Answer: Historically, each National Health Service trust has had a separate Laboratory Information and Management System (LIMS), which precludes the seamless digital sharing of pathology results and reports between trusts.NHS England has provided funding and expe...
Answered 29 Jun 2026
Original Parliament recordOut-patients and Phlebotomy: Digital TechnologyDepartment of Health and Social CareTabled 15 Jun 2026AnsweredUIN 9770More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the resilience of digital appointment booking systems used by NHS phlebotomy and outpatient services; and what steps he is taking to ensure that patients
Answer: Each National Health Service provider is responsible for the procurement and operation of appointment booking systems, as well as communication with patients about their appointments. National guidance expects trusts to use the Digital Technology Assessme...
Answered 29 Jun 2026
Original Parliament recordDementia: Respite CareDepartment of Health and Social CareTabled 1 Jun 2026AnsweredUIN 5689More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of availability of respite care for unpaid carers of people living with dementia; and what steps he is taking to improve access to those serv
Answer: The Government recognises the vital role that unpaid carers play in supporting people living with dementia and is committed to ensuring that carers can access appropriate support, including respite services.Responsibility for commissioning respite service...
Answered 5 Jun 2026
Original Parliament recordMedicine: ResearchDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 1095More
Question: To ask the Secretary of State for Health and Social Care, what the annual expenditure by the National Institute for Health and Care Research on research workforce development programmes, including fellowships, training awards and capacity-building initiat
Answer: Through the National Institute of Health and Care Research, the Department invests in building research expertise and capacity, specialist facilities, and support services to support research across all aspects of human health, including dementia, cancer,...
Answered 22 May 2026
Original Parliament recordSchool MilkDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 1084More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on reception year pupils of the age based eligibility threshold for the Nursery Milk Scheme; and whether he is taking steps to ensure consisten
Answer: The Nursery Milk Scheme is a statutory scheme which allows early years childcare settings to reclaim the cost of providing one-third of a pint of milk per day to children under the age of five who attend a setting for two or more hours per day. Schools ca...
Answered 26 May 2026
Original Parliament recordBowel Cancer: Medical TreatmentsDepartment of Health and Social CareTabled 16 Apr 2026AnsweredUIN 128021More
Question: To ask the Secretary of State for Health and Social Care, whether his Department is working with the National Institute for Health and Care Excellence to introduce a stand-alone clinical rule for suspected bowel cancer, including for patients under 50, to
Answer: The National Institute of Health and Care Excellence (NICE) is an independent body and is responsible for making decisions on whether its published guidelines should be updated in light of new evidence or emerging issues not in the scope of the original g...
Answered 24 Apr 2026
Original Parliament recordSkin Diseases: Steroid DrugsDepartment of Health and Social CareTabled 16 Apr 2026AnsweredUIN 128007More
Question: To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure patients prescribed topical corticosteroids are informed of potential risks, including withdrawal reactions.
Answer: Clinicians are expected to work with patients to make decisions about their care and treatment as part of shared decision-making, including discussing risks, benefits, and possible consequences of different options through information-sharing. Further inf...
Answered 22 Apr 2026
Original Parliament recordSkin Diseases: Steroid DrugsDepartment of Health and Social CareTabled 16 Apr 2026AnsweredUIN 128006More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve awareness and clinical recognition of Topical Steroid Withdrawal among GPs, dermatologists and other healthcare professionals.
Answer: Topical corticosteroids are an important and effective treatment for inflammatory skin conditions, including eczema, when used appropriately. It is essential that healthcare professionals are aware of both the benefits and potential risks associated with ...
Answered 22 Apr 2026
Original Parliament recordSkin Diseases: Steroid DrugsDepartment of Health and Social CareTabled 16 Apr 2026AnsweredUIN 128005More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to introduce updated clinical (a) guidance and (b) training for healthcare professionals on the identification and management of Topical Steroid Withdrawal.
Answer: Topical corticosteroids are an important and effective treatment for inflammatory skin conditions, including eczema, when used appropriately. It is essential that healthcare professionals are aware of both the benefits and potential risks associated with ...
Answered 22 Apr 2026
Original Parliament recordPolio: SewersDepartment of Health and Social CareTabled 10 Apr 2026AnsweredUIN 126355More
Question: To ask the Secretary of State for Health and Social Care, what assessment the UK Health Security Agency has made of the public health risk associated with poliovirus detections in wastewater surveillance systems in the last 12 months.
Answer: The UK Health Security Agency, working with the World Health Organization Polio Global Specialised Laboratory and the Medicines and Healthcare products Regulatory Agency, conducts routine environmental surveillance for polio in England as part of our comm...
Answered 20 Apr 2026
Original Parliament recordMedical TreatmentsDepartment of Health and Social CareTabled 17 Mar 2026AnsweredUIN 121660More
Question: To ask the Secretary of State for Health and Social Care, if NHS England Specialised Commissioning will consider a second prioritisation meeting this year of the Clinical Priorities Advisory Group to reduce the 20 treatments currently being considered, in
Answer: NHS England’s Clinical Priorities Advisory Group (CPAG) prioritisation meetings are held annually and are aligned to NHS England's annual financial planning cycle.The next prioritisation meeting is planned for spring 2026, where policies that are ready an...
Answered 25 Mar 2026
Original Parliament recordMedical Treatments: FinanceDepartment of Health and Social CareTabled 17 Mar 2026AnsweredUIN 121658More
Question: To ask the Secretary of State for Health and Social Care, what level of recurrent funding has been identified by NHS England to fund the recommendations of new treatments considered by NHS England’s next Clinical Priorities Advisory Group Prioritisation m
Answer: NHS England is not able to provide the level of recurrent funding identified at this point to support the next Clinical Priorities Advisory Group prioritisation meeting. This would risk disclosing commercially confidential information.
Answered 25 Mar 2026
Original Parliament recordDiabetes: WomenDepartment of Health and Social CareTabled 3 Mar 2026AnsweredUIN 117599More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of women's health pathways in providing structured nutritional and metabolic support to women experiencing early endocrine and metabolic symptoms before
Answer: The Department has not made a specific assessment. However, the Government is committed to tackling preventable ill health such as type 2 diabetes. Referrals to digital weight management services are offered where appropriate, and lifestyle advice, diet, ...
Answered 30 Mar 2026
Original Parliament recordDepartment of Health and Social Care: Personnel ManagementDepartment of Health and Social CareTabled 23 Feb 2026AnsweredUIN 115311More
Question: To ask the Secretary of State for Health and Social Care, how many directors with responsibility for human resources are employed across their department and its executive agencies; and how many of those directors hold professional HR qualifications from
Answer: The Department and its executive agencies currently employ three people at director-level with responsibility for human resources (HR). All three hold professional HR qualifications from the Chartered Institute of Personnel and Development.
Answered 3 Mar 2026
Original Parliament recordEndometriosis: TrainingDepartment of Health and Social CareTabled 20 Feb 2026AnsweredUIN 114541More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that endometriosis is adequately covered in the education and training of healthcare practitioners.
Answer: The Government acknowledges the challenges faced by women with endometriosis and the impact it has on their lives, their relationships, and their participation in education and the workforce.The Government also acknowledges the importance of ensuring heal...
Answered 2 Mar 2026
Original Parliament recordMedical TreatmentsDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110663More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the backlog for NHS England’s Clinical Priorities Advisory Group Prioritisation meeting.
Answer: The next Clinical Priorities Advisory Group (CPAG) prioritisation meeting is planned for spring 2026, where policies that are ready and require investment decisions to be taken will be considered. It is expected up to 20 such policies will be considered a...
Answered 24 Feb 2026
Original Parliament recordMedical Treatments: FinanceDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110662More
Question: To ask the Secretary of State for Health and Social Care, what level of recurrent funding has been identified to fund new treatments through NHS England’s Clinical Priorities Advisory Group Prioritisation meeting.
Answer: The Clinical Priorities Advisory Group is an advisory committee that makes recommendations on the relative priority of treatments to be commissioned subject to the available discretionary funding. It is not a decision-making body and does not allocate fun...
Answered 9 Feb 2026
Original Parliament recordMedical TreatmentsDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110661More
Question: To ask the Secretary of State for Health and Social Care, how many times NHS England’s Clinical Priorities Advisory Group Prioritisation meeting happens each year; and when the next meeting will be.
Answer: NHS England’s Clinical Priorities Advisory Group (CPAG) meets monthly to consider policy and service specifications that are categorised as cost saving or cost neutral. CPAG prioritisation meetings are held annually. The next prioritisation meeting is pla...
Answered 24 Feb 2026
Original Parliament recordTrade Agreements: USADepartment of Health and Social CareTabled 26 Jan 2026AnsweredUIN 108527More
Question: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the UK-US Pharmaceuticals Deal concluded in December 2025 on (a) NHS procurement costs and (b) consumer access to affordable medicines befor
Answer: There are no current plans to publish an impact assessment or modelling on the United Kingdom and United States’ pharmaceutical trade deal. Further detail on the deal will be shared in due course.Tens of thousands of National Health Service patients will ...
Answered 2 Feb 2026
Original Parliament recordComplex Regional Pain Syndrome: Medical TreatmentsDepartment of Health and Social CareTabled 19 Jan 2026AnsweredUIN 106878More
Question: To ask the Secretary of State for Health and Social Care, what the process is for evaluating new medical devices for the treatment of chronic neuropathic pain conditions for use in the NHS.
Answer: The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest stan...
Answered 26 Jan 2026
Original Parliament recordComplex Regional Pain Syndrome: Medical TreatmentsDepartment of Health and Social CareTabled 19 Jan 2026AnsweredUIN 106877More
Question: To ask the Secretary of State for Health and Social Care, whether NICE has been asked to evaluate Scrambler Therapy for the treatment of Complex Regional Pain Syndrome.
Answer: The National Institute for Health and Care Excellence (NICE) has not been asked to evaluate scrambler therapy for complex regional pain syndrome. Topics for new or updated guidance are considered through the NICE prioritisation process and under this proc...
Answered 26 Jan 2026
Original Parliament recordNon-surgical Cosmetic Procedures: LicensingDepartment of Health and Social CareTabled 5 Jan 2026AnsweredUIN 103133More
Question: To ask the Secretary of State for Health and Social Care, with reference to his Department's document entitled The licensing of non-surgical cosmetic procedures in England: consultation response, updated on 7 August 2025, what progress has been made on im
Answer: On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are bro...
Answered 12 Jan 2026
Original Parliament recordNon-surgical Cosmetic Procedures: LicensingDepartment of Health and Social CareTabled 5 Jan 2026AnsweredUIN 103132More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of Scotland's proposed regulation of non-surgical cosmetic procedures on England's regulatory framework; and, with reference to his Department's
Answer: On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are bro...
Answered 12 Jan 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →